Valneva SE ADR
Price & Volume
Stats
See more52W Range | $4.75-$12.18 |
Market Cap | $548M |
Shares Short | 206,846 |
Financials
See moreRevenue (12 Mos) | $142.9M |
Revenue Growth (YoY) | -27.7% |
Gross Profit (12 Mos) | -$59.6M |
Diluted EPS | -$2.10 |
News
See moreYahoo Finance • 26 days ago
Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat
Yahoo Finance • last month
The Bull Case For Pfizer (PFE) Could Change Following New COVID And Lyme Vaccine Milestones - Learn Why
Yahoo Finance • 2 months ago
Pfizer (PFE) Stock Looks Reasonable On Returns But Stretched On Earnings
Yahoo Finance • 2 months ago
Valneva GAAP EPS of -€0.35, revenue of €65.84M; reaffirms FY 2026
About
CEO | Mr. Thomas Lingelbach |
Address | 6 rue Alain Bombard, Saint-Herblain, France, 44800 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 620 |